Kazakhstan vs Mongolia: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Kazakhstan
78.0%
in 2014
Mongolia
75.0%
in 2014
Kazakhstan rank
58th
Mongolia rank
61st
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Kazakhstan
- Mongolia
How they compare
Kazakhstan currently reports 78.0% against 75.0% in Mongolia, a difference of 3.0%.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Mongolia ahead.
Kazakhstan ranks 58th and Mongolia ranks 61st of 104 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kazakhstan | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.5% | 83.2% | 56.8% | Mongolia |
| 2010s | 45.4% | 73.0% | 27.6% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Kazakhstan or Mongolia?
- Kazakhstan, at 78.0% against 75.0% in Mongolia as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Kazakhstan and Mongolia?
- 3.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Mongolia?
- 9 years are reported by both, from 2005 to 2014.
- How do Kazakhstan and Mongolia rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Kazakhstan ranks 58th and Mongolia ranks 61st of 104 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.